Colonial Trust CO / Sc Repligen Corp Transaction History
Colonial Trust CO / Sc
- $672 Million
- Q2 2025
Number of Shares
0Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
506Shares Held
58.9MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.17 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$1.02 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$785 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$296 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$251 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.58B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....